COVID-19 Researchers to Meet Hades |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.17, No. 4)Publication Date: 2022-11-22
Authors : Martti Antila;
Page : 403-404
Keywords : Therapy; Humanigen; Janssen; Novartis; Sanofi Genzyme; Angion Biomedica;
Abstract
Before the COVID-19 pandemic to encounter Hades was a somewhat romantic affair as it was inevitable but far away in the future [1]. However, COVID-19 has spread globally, affecting an increasing number of countries. On March 11, 2020, WHO characterized the COVID-19 outbreak as a pandemic as global rates of cases and deaths continued to increase [2,3]. After the start of the pandemic, healthcare workers, especially the doctors in many countries appeared victims of this serious, highly lethal disease taking them quickly to meet Hades [4,5].
Other Latest Articles
- An Atypical Presentation of Non-Gestational Choriocarcinoma During the COVID-19 Pandemic: A Case Report |Biomedgrid
- Cell Free Fetal DNA As Biomarker for Pregnancy Loss Disorders |Biomedgrid
- INDIA AND THE GLOBAL SOUTHSTRATEGY-FOCUSING ON DIPLOMATIC RELATIONS WITH AFRICA
- PRESCRIPTION DES PSYCHOTROPES EN MEDECINE DE PREMIERE LIGNE DANS LA PRISE EN CHARGE DES TROUBLES MENTAUX AU MALI
- DIGITAL TECHNOLOGIES IN DENTAL PRACTICE: A PARADIGM SHIFT
Last modified: 2024-07-12 21:54:16